[AAV-CRISPR/Cas9-介导血友病A基因疗法的进展 - 评论]
Shuai Fang1,2, Gang Wang2, Lin-Hua Yang2
1Department of Biochemistry and Molecular Biology, School of Basic Medicine, Shanxi Medical University.
Zhongguo shi yan xue ye xue za zhi
|December 9, 2023
概括
使用CRISPR-Cas9的基因疗法为血友病A (HA) 提供了一个有前途的新疗法,这是一种X相关的出血障碍. 这种方法使得有针对性的基因编辑能够有效地表达治疗性第八因子变异.
科学领域:
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
- 血液学 血液学 血液学
背景情况:
- 血友病A (HA) 是一种显著的X相关的衰退性出血障碍,由凝血因子VIII基因突变引起.
- 目前的治疗主要涉及外源性VIII因子替代疗法,这可能是繁重和终身的.
- 基因疗法为A型血友病提供了一种新且潜在的治疗方法.
结论:
- 克里斯普尔-Cas9技术在推进血友病A基因治疗方面具有显著的潜力.
- 本综述综合了目前关于矢量设计,基因构造和HA治疗编辑策略的研究.
- 高效和安全的基因编辑工具的开发正在为遗传性出血障碍的新治疗范式铺平道路.
相关概念视频
01:59CRISPR
51.6K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
51.6K
00:59Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K